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Clostridium difficile infection (CDI) is a significant health problem worldwide. Control and prevention 
strategies of C. difficile horizontal transmission require assays with fast detection with high specificity 
and sensitivity. Conventional diagnostic methods are time consuming and costly for clinical field 
settings. This study aims to develop gold nanoparticles (AuNPs)-based assay for direct qualitative 
detection of the nucleic acid of C. difficile and its toxins. A colloidal solution of AuNPs with a diameter 
of 13±1 nm was prepared and characterized. The qualitative colorimetric AuNPs assay was developed 
for restricted genomic C. difficile DNA detection, and results were confirmed by PCR. One hundred and 
five positive C. difficile isolates were collected from patients with diarrheal diseases and tested using 
AuNPs based-assay. Ninety-six samples (91.4%) were detected positive using AuNPs based assay, as 
indicated by the color change from red to blue within 1 min. All ninety-six positive samples were 
positive for toxin B. In conclusion, nano-gold assay prototype was developed for direct and inexpensive 
detection of C. difficile. The developed prototypes are simple, sensitive, rapid and can substitute PCR-
based detection. The developed assay may show potential in the clinical diagnosis of C. difficile, 
especially in developing countries as it is less costly as compared to the commercially available 
assays. 
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INTRODUCTION 
 
Clostridium difficile is a Gram-positive, strictly anaerobic, 
spore-forming bacterium (Chankhamhaengdecha et al., 
2013), first recognized in the late 1970s (Burnham and 
Carroll, 2013). It is documented as the causative agent of  
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a broad spectrum of intestinal diseases ranging from mild 
self-limiting diarrhea to more serious and potentially life 
threatening manifestations such as Pseudomembranous 
colitis and is responsible for most cases of antibiotic-
associated diarrhea (Carter et al., 2007; Goncalves and 
Decre, 2004). Pathogenicity of C. difficile is linked to two 
major toxins produced by the bacteria: toxins A 
(enterotoxin) and B (cytotoxin). Toxins A and B are 
encoded by the genes tcdA and tcdB, respectively, and 
are located in the 19.6-kb pathogenicity locus (PaLoc) of 
the C. difficile chromosome (Persson et al., 2011). Some 
strains of C. difficile also secrete binary toxin. CdtA and 
cdtB genes that are located outside the PaLoc 
(Goncalves and Decre, 2004) encode these binary toxins. 
Rapid and reliable identification of toxigenic C. difficile 
is essential for appropriate patient management and 
implementation of timely infection control measures due 
to the rapidly increasing infection rate of C. difficile in 
health care facilities. Current laboratory diagnosis 
remains challenging with many limitations, as rapid test 
procedures relying on enzyme immunoassays (EIAs) 
show limited sensitivity. On the other hand, the gold 
standard toxigenic culture and cytotoxicity assays, which 
are considered as reference standard, are time-
consuming (Dalpke et al., 2013). A two-step algorithms 
consisting of sensitive detection of glutamate 
dehydrogenase enzyme (GDH) followed by a 
confirmatory test using PCR have been proposed by  
Ticehurst et al. (2006) to increase sensitivity and 
specificity of the detection.  
Gold has been used as a vital material in 
nanotechnology and incorporated in diagnostic 
procedures. Distinctive size-dependent optical properties 
of AuNPs, their inertness and strength make them one of 
the most robust materials utilized in nano diagnostics 
technology (Syed, 2014). They are spherical in shape 
with a typical diameter of approximately 2 to 100 nm that 
exhibit a unique phenomenon known as “localized 
surface plasmon resonance” or LSPR, which is 
responsible for their intense red color. Upon aggregation, 
AuNPs change color and that is easily detected visually 
without the aid of any instrumentation. Addition of salt 
(NaCl) during hybridization shields the surface charge on 
the AuNPs, which are typically negatively charged due to 
reduced citrate ions on their surfaces, leading to 
aggregation of AuNPs and thus change in color from red 
to blue (Hussain et al., 2013; Syed, 2014). This property 
is especially useful in colorimetric detection based assay, 
which is evaluated in this study (Azzazy et al., 2006; 
Jennings and Strouse, 2007; West and Halas, 2003). The 
principle of colorimetric AuNPs-based assay in microbial 
identification is illustrated in Figure 1. 
To the best of the authors’ knowledge, this is the first 
study aimed to develop unmodified AuNPs - based assay 
for direct qualitative detection of the nucleic acid of C. 
difficile and its toxins. Additionally, it evaluated AuNPs 
assay sensitivity and specificity as compared to RT-PCR  
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Figure 1. Schematic diagram illustrating the principle of 
colorimetric AuNPs-based assay in microbial 
identification. In positive samples, the primer is 
complementary to the DNA/RNA target, thus not 
available in the hybridization buffer, containing NaCl to 
protect and stabilize AuNp, leading to aggregation of 
AuNPs and blue color formation. On the other hand, in 
the absence of the target or non-specific DNA, the primer 
will be free in the reaction mixture and binds to AuNPs 
preventing aggregation and the color remains unchanged. 
 
 
 
(GeneXpert, Cepheid, CA, USA). 
 
 
MATERIALS AND METHODS 
 
Synthesis of AuNPs 
 
Spherical AuNPs were prepared by citrate reduction of gold 111 
chloride trihydrate (HAuCl4.3H2O). Synthesis was carried out as 
previously prescribed by Grabar et al. (1995). Briefly, the reflux 
system was cleaned by aqua regia and then rinsed with ultrapure 
water and left to dry. An aqueous solution of 1 Mm HAuCl4.3H2O 
(Sigma Aldrich) was brought to boil under reflux conditions while 
stirring. When gold started to boil, 1% of trisodium citrate (Sigma 
Aldrich) was rapidly added. This resulted in a subsequent change in 
solution color from yellow - clear - black - purple - deep red. 
Afterwards, the solution was then refluxed for an additional 15 min 
and subsequently allowed to cool to room temperature. The 
colloidal solution was then stored into a clean dark storage glass 
bottle at 4°C until further use. 
 
 
Characterization of AuNPs 
 
The absorbance of the prepared AuNPs solution was measured by 
Agilent 8453 UV-visible spectrophotometer at wavelength 400 to 
700 nm. The size and distribution was characterized using Zeta 
sizer (Malvern, Nano ZSP, UK) based on light scattering principle 
and scanning electron microscope, SEM (FE1 NOVA-NanoSEM, 
450, USA). The recommended AuNPs size  ranges  from  12  to  15   
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nm with the absorbance of the visible range 400 to 700nm (Grabar 
et al., 1995). 
 
 
Collection of bacterial isolates 
 
A total of 105 C. difficile clinical isolates used in this study were, 
originally provided for routine laboratory diagnosis at Hamad 
Medical Corporation (HMC) - Al Khor Hospital, Qatar during the 
period of 2011 to 2012. Cryopreserved C. difficile isolates were 
revived and sub-cultured onto blood agar enrichment medium, and 
incubated anaerobically. Samples were transported to Qatar 
University (Biomedical Research Center) for DNA extraction and 
testing with gold nanoparticles-based assay. Isolates were 
confirmed to be C. difficile using RT-polymerase chain reaction, RT-
PCR, (GeneXpert, Cepheid, CA, USA). According to RT- PCR 
results, all C. difficile isolates (105) were positive for toxin B. Twenty 
nine additional ATCC bacterial isolates other than C. difficile were 
used to assess specificity of the assay. The Research Ethical 
Committee of Hamad Medical Corporation, Qatar, approved the 
study. 
 
 
DNA extraction 
 
Genomic DNA was extracted from bacterial cultures following 
manufacturer's instructions of QIAamp DNA Mini kit (Qiagen; Cat. 
No. 51306). 
 
 
Restriction of genomic C. diff DNA 
 
The entire extracted genomic C. diff DNA was digested using Bam 
HI, according to the conditions recommended by the supplier of the 
enzyme kit (Promega). Briefly, 17.3 µl of the extracted genomic 
DNA were restricted by addition of 0.5 µl of the enzyme, 2 µl of the 
buffer, 0.2 µl of the acetylated bovine serum albumin. Then 
incubated at 37°C for 1 h after that inactivated at 65°C for 20 min. 
 
 
Colorimetric AuNPs assay for detection of C. difficile DNA: 
Development and optimization 
 
The colorimetric qualitative AuNPs assay for C. difficile was 
optimized through adjustment of the assay parameters such as 
annealing temperature, salt concentration and targeting 
oligonucleotide sequences. Different concentrations of NaCl and 
primer concentrations were tested to determine the optimum 
concentrations for performing the assay (data not shown). 
Hybridization buffer was prepared using 0.50 M NaCl and 10 μM 
primer. Different volumes of the AuNPs were tested, and 25 μL of 
the prepared AuNPs (12 to 15 nm) was selected for use in the final 
assay. Forward CD-R 5’- CCC TGC ACC CTT AAT AAC TTG ACC- 
3’ (Integrated DNA Technologies, Inc. Belgium) primer was used in 
the assay due to its high specificity to all C. difficile. The assay was 
performed as follows: 22 μL of the extracted DNA (1.7ng/μl), were 
placed in a sterile PCR tube. Then, 13 μL of the hybridization buffer 
were added and mixed well (final concentration of the primer and 
NaCl after addition of AuNPs were 0.9 μM and 0.04 M, respectively) 
to obtain a final volume of 35 μl per PCR tube. The mixture was 
then heated at 95°C for 30 s, and annealed at 50°C for 30 s and 
then cooled to room temperature for 10 min. 25 μl of colloidal 
AuNPs were then added to the mixture, and the color was observed 
within 1 min (Shawky et al., 2010). 
 
 
Colorimetric AuNPs assay for detection of C. difficile toxin B 
 
All  C. difficile  positive  samples  were  further  tested  for   toxin   B  
 
 
 
 
following similar methods for detection of C. diff DNA by AuNPs but 
using specific toxin B (Ted B) primer (5-CAC GCC TGG AGA ATC 
TAT ATT TGT AGA AA-3). 
 
 
RESULTS 
 
Characterization of AuNPs  
 
The SEM image (Figure 2) showed that the synthesized 
AuNPs prepared in our laboratory were well dispersed 
and spherical in shape. The extinction spectrum of the 
prepared AuNPs demonstrated a single peak in the 
visible region (400 to 700nm) with λmax at 519 to 521 nm 
(Figure 3). The diameter of AuNPs was found to be 13±1 
nm (Figure 4), as characterized by both SEM and Zeta 
sizer. 
 
 
C. difficile gold nanoparticles assay prototype 
 
Optimization of the AuNPs-based assay is affected by 
four main factors namely, concentrations of NaCl, AuNPs 
size, primer and the assay annealing temperature. In the 
positive samples, blue color indicates the presence of 
primers complementary to the C. difficile DNA sequence 
and this leads to the aggregation of AuNPs. On the other 
hand, red color indicates that the primer is free in the 
mixture that leads to stabilization of AuNPs and prevents 
their aggregation. Any minimal change in color from red 
to blue or purple is considered as a positive result (Figure 
5).  
Ninety six (96) out of 105 (91.4%) C. diff positive samples 
showed blue and 9 out of 105 (8.6%) showed a red color. 
The nine negative samples were retested and yielded 
same results (Figure 6). Reference strain E. coli ATCC 
25922, Bacteroides fragilis, Peptostreptococcus 
anaerobious and Campylobacter jejuni tested negvative 
with our assay as expected (Figure 6B). Additionally, all 
twenty-nine ATCC strains of Clostridium species other 
than C. diff were also tested negative with AuNPs-based 
assay (red color) (Figures 6A, B and C) indicating high 
specificity.Control 
 
 
Assay performance assessment 
 
No cross-reactivity was observed between C. difficile and 
other bacteria tested (Figure 6). The AuNPs-based assay 
performance was then compared with commercially 
available RT-PCR (GeneXpert, Cepheid, USA), and 
yielded 91.4% positivity, all samples were positive with 
RT-PCR.  
 
 
Gold nanoparticles assay to detect C. diff toxin B 
 
The assay was then optimized to detect toxin B 
gene(tcdB) of C.  difficile. All ninety-six  samples  positive  
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Figure 2. SEM image showing spherical AuNPs, with a size of 13±1 nm, 
prepared using citrate reduction method. The image was analyzed using 
the professional image analysis software (Clemex vision P.E 4).  
 
 
 
 
 
Figure 3. Extinction spectra of the prepared AuNPs solution. The peak is 
displayed in the visible light region with λmax 518-521 nm. 
 
 
 
with C. difficile prototype detection assay were also 
positive for toxin B gene (Figure 7). Equivalent result was 
obtained when using RT-PCR method. C. perfringens 
ATCC 13124 was used as a negative  control  in  toxin  B  
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Figure 4. Dynamic light scattering analysis of size distribution of the 
prepared AuNPs using Zetasizer Nano ZSP (Malvern, UK). The peak 
represents the number (percent) of AuNPs that have size between 12 and 15 nm. 
 
 
 
 
 
Figure 5. Qualitative AuNPs-based assay for C. difficile detection. Positive 
control (+ctr) = blue, Negative control (-ctr) = red. E.coli ATCC 25922 as 
negative control = red. A) All C. difficile samples were positive (change in 
color from red to blue). B) All C. difficile samples were positive (blue color) 
except 36, 61 and 68. C) Negative samples were retested and yielded the 
same results. 
A 
 
 
B 
 
 
C 
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Figure 6. Qualitative AuNPs based assay for isolates other than C. difficile and other 
Clostridium species. Positive control (+ctr) = blue, Negative control (-ctr) = red. All samples 
were negative (red color). E.coli ATCC 25922 as negative control = red. BF: 
Bacteroides fragilis, Pepto: Peptostreptococcus anaerobious and Camp: Campylobacter 
jejuni. 
 
 
 
 
 
Figure 7. Qualitative AuNPs based assay for C. difficile toxin B detection positive control (+ctr) = blue, Negative control (-ctr) 
= red, Clost.: C. perfringens ATCC 13124 and E. coli ATCC 25922 as negative control= red. All samples were positive (blue 
color).  AuNP: Gold nanoparticles; +ctr: Positive control; -ctr: Negative control; BF: Bacteroides fragilis; Pepto.: 
Peptostreptococcus anaerobious; Camp: Campylobacter jejuni; cdtA & cdtB: Binary toxins; Clost.: Clostridum. Perfringens; 
C. diff: Clostridium difficile 
762         Afr. J. Microbiol. Res. 
 
 
 
detection with AuNPs. 
 
 
DISCUSSION  
 
AuNPs-based methods have been established for 
detection of several pathogenic organisms such as 
Mycobacterium tuberculosis (MTB), Hepatitis C virus 
(HCV), methicillin resistant Staphylococcus aureus 
(MRSA) and others, owing to the high sensitivity and 
specificity of AuNPs- based assays for detection of 
nucleic acid targets (Shawky et al., 2010; Hussain et al., 
2013). AuNPs study carried out by Shawky et al. (2010), 
showed sensitivity and specificity of 93.3 and 88.9%, 
respectively, in detecting HCV. Another study by Hussain 
et al. (2013). indicated 96.6% sensitivity and 98.9% 
specificity for the detection of M. tuberculosis complex 
(MTBC) and 94.7% sensitivity and 99.6% specificity for 
the detection of MTB. These results are consistent with 
our findings in this study which, demonstrated 91.4% 
sensitivity and 100% specificity as compared to RT-PCR. 
PCR assays include amplification steps and has always 
been considered more sensitive than 
enzymetic/cloromertic assays. Additionaly, the lower 
sensitivity of AuNPs- assay (91.4%) could be clarified by 
the following reasons, 1) possible loss of the targeted 
genes due to long cryoperservation period, 2) PCR does 
not cover the same region used to design the primers for 
PCR.  
Different gold nanoparticles approaches have been 
explored to detect C. difficile and its toxins, such as using 
an aptamer biosensor with gold nanoparticles 
synthesized by Bacillus stearothermophilus (Luo et al., 
2013). Additionally, Zhu et al. (2015) considered the use 
of single domain antibody coated gold nanoparticles as 
enhancer for C. difficile toxin detection by electro 
chemical impedance immunosensors. This confirms that 
using AuNPs with different methodologies resulted in 
excellent performance with high sensitivity and is in 
concordance with our findings.  
This study revealed that AuNPs-based assay could be 
used to detect C. difficile and C. difficile toxin B from 
unamplified genomic DNA with detection limit of 35.5 ng 
DNA. The assay was highly sensitive, specific, rapid, 
simple and minimized the need for expensive and 
complex equipment. Cost effectiveness is one of the 
advantages of synthesis of AuNPs that was explored in 
this study. The approximate cost of 1 g of gold chloride is 
220 US Dollars which is enough to conduct 40,000.00 
assays, as compared to ~ 55 USD per test for RT-PCR, 
(GeneXpert, Cepheid, CA, USA). Additionally, the 
prepared gold nanoparticles have a long shelf life and 
can be stored at 4°C for one year or more. Moreover, this 
method has short turnaround time, only 15 to 20 min, 
after DNA extraction; consequently, the method can be 
utilized by many laboratories especially in low-income 
countries with low resources. This developed  assay  may  
 
 
 
 
improve the management of C. difficile infection by early 
isolation of infected patient to prevent horizontal 
transmission in health care facilities, and may lead to a 
more rational use of antibiotics, as the clinicians will 
rapidly obtain the clinical microbiology results. 
 
 
Conclusions 
 
In conclusion, this assay will have a crucial and great 
impact on clinical diagnosis in low-resources countries in 
terms of patient’s management and infection control 
measures. Moreover, the assay can compete with RT-
PCR since it has comparable performance results. 
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